These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
34. TMP-153, a novel ACAT inhibitor, inhibits cholesterol absorption and lowers plasma cholesterol in rats and hamsters. Sugiyama Y; Ishikawa E; Odaka H; Miki N; Tawada H; Ikeda H Atherosclerosis; 1995 Feb; 113(1):71-8. PubMed ID: 7755657 [TBL] [Abstract][Full Text] [Related]
35. Inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT) as hypocholesterolemic agents: synthesis and structure-activity relationships of novel series of sulfonamides, acylphosphonamides and acylphosphoramidates. Lee HT; Roark WH; Picard JA; Sliskovic DR; Roth BD; Stanfield RL; Hamelehle KL; Bousley RF; Krause BR Bioorg Med Chem Lett; 1998 Feb; 8(3):289-94. PubMed ID: 9871672 [TBL] [Abstract][Full Text] [Related]
36. Inhibitors of acyl-CoA:cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. 8. Incorporation of amide or amine functionalities into a series of disubstituted ureas and carbamates. Effects on ACAT inhibition in vitro and efficacy in vivo. O'Brien PM; Sliskovic DR; Blankley CJ; Roth BD; Wilson MW; Hamelehle KL; Krause BR; Stanfield RL J Med Chem; 1994 Jun; 37(12):1810-22. PubMed ID: 8021920 [TBL] [Abstract][Full Text] [Related]
37. Pharmacological properties of R-755, a novel acyl-CoA:cholesterol acyltransferase inhibitor, in cholesterol-fed rats, hamsters and rabbits. Matsui Y; Horiuchi K; Yamamoto K; Kanai K Jpn J Pharmacol; 2001 Apr; 85(4):423-33. PubMed ID: 11388647 [TBL] [Abstract][Full Text] [Related]
38. Inhibitors of acyl-CoA: cholesterol acyltransferase. II. Preparation and hypocholesterolemic activity of optically active dibenz[b,e]oxepin-11-carboxanilides. Kumazawa T; Yanase M; Shirakura S; Ohishi E; Yamada K; Matsumiya S; Kono M Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):222-5. PubMed ID: 8582041 [TBL] [Abstract][Full Text] [Related]
39. Novel hydroxyphenylurea dual inhibitor against acyl-CoA: cholesterol acyltransferase (ACAT) and low density lipoprotein (LDL) oxidation as antiatherosclerotic agent. Nakao K; Kubota H; Yasuhara M; Saito K; Suzuki T; Ohmizu H; Shimizu R Bioorg Med Chem; 2001 Apr; 9(4):853-61. PubMed ID: 11354668 [TBL] [Abstract][Full Text] [Related]
40. Hypolipidaemic properties of a potent and bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor (RP 73163) in animals fed diets low in cholesterol. Riddell D; Bright CP; Burton BJ; Bush RC; Harris NV; Hele D; Moore UM; Naik K; Parrott DP; Smith C; Williams RJ Biochem Pharmacol; 1996 Oct; 52(8):1177-86. PubMed ID: 8937424 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]